Met Life Investment Management, LLC Veracyte, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 46,945 shares of VCYT stock, worth $1.93 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,945
Previous 43,867
7.02%
Holding current value
$1.93 Million
Previous $1.49 Million
24.6%
% of portfolio
0.01%
Previous 0.01%
Shares
40 transactions
Others Institutions Holding VCYT
# of Institutions
336Shares Held
81.1MCall Options Held
202KPut Options Held
18.6K-
Vanguard Group Inc Valley Forge, PA8.21MShares$338 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$320 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$271 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$173 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$168 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.94B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...